The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study
Crossref DOI link: https://doi.org/10.1007/s00125-014-3458-7
Published Online: 2014-11-26
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ong, Kwok-Leung
Januszewski, Andrzej S.
O’Connell, Rachel
Jenkins, Alicia J.
Xu, Aimin
Sullivan, David R.
Barter, Philip J.
Hung, Wei-Ting
Scott, Russell S.
Taskinen, Marja-Riitta
Keech, Anthony C.
Rye, Kerry-Anne
Text and Data Mining valid from 2014-11-26